Alessia Donadio, MD

Current Trials

• SIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 Multi-Institution Randomized Prospective Clinical Trial Evaluating the Impact of Cytoreductive Radical Prostatectomy Combined With Best Systemic Therapy on Oncologic and Quality of Life Outcomes in Men With Newly Diagnosed Metastatic Prostate Cancer

  HIC ID2000031290RoleSub InvestigatorPrimary Completion Date10/31/2024

  Recruiting ParticipantsGenderMaleAge18+ years

  Prostate Cancer

• The CompassHER2 Trials (Comprehensive Use of Pathologic Response Assessment to Optimize Therapy in HER2-Positive Breast Cancer) CompassHER2 Residual Disease (RD), a Double-Blinded, Phase III Randomized Trial of T-DM1 Compared With T-DM1 and Tucatinib

  HIC ID2000030282RoleSub InvestigatorPrimary Completion Date01/01/2028

  Recruiting Participants

  Breast Cancer

• A Randomized Phase II Trial Of Circulating Tumor DNA-Guided Second Line Adjuvant Therapy For High Residual Risk, Stage II-III, Hormone Receptor Positive, HER2 Negative Breast Cancer

  HIC ID2000029678RoleSub InvestigatorPrimary Completion Date12/15/2023

  Recruiting Participants

  Breast Cancer

• Randomized Non-Inferiority Trial Comparing Overall Survival of Patients Monitored With Serum Tumor Marker Directed Disease Monitoring (STMDDM) Versus Usual Care in Patients With Metastatic Hormone Receptor Positive Breast Cancer

  HIC ID2000024170RoleSub InvestigatorPrimary Completion Date01/01/2035

  Recruiting Participants

  Breast Cancer